Gilles Manceau (Julien Taieb)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 55

Top Venues

British journal of cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancers

Clinical cancer research : an official journal of the American Association for Cancer Research

Université de Paris

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Université de Paris Jun 01 2007

France

Professor Head of the department :: GI oncology

Publications

Sophie Mouillet-Richard, Antoine Cazelles, Marine Sroussi, Claire Gallois, Gilles Manceau, Pierre Laurent-Puig
Clinical Challenges of Consensus Molecular Subtype CMS4 Colon Cancer in the Era of Precision Medicine. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Sophie Mouillet-Richard, Antoine Cazelles, Marine Sroussi, Claire Gallois, Gilles Manceau, Pierre Laurent-Puig
Clinical challenges of consensus molecular subtype CMS4 colon cancer in the era of precision medicine. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Gwénaël Le Teuff, Nathalie Cozic, Jean-Christophe Boyer, Valérie Boige, Robert B Diasio, Gilles Manceau, Didier Meulendijks, Claire Palles, Matthias Schwab, Maarten Deenen, Carlo R Largiadèr, Anthony Marinaki, Barbara A Jennings, Yvonne Wettergren, Antonello Di Paolo, Eva Gross, Barna Budai, Stephen P Ackland, André B P van Kuilenburg, Howard L McLeod, Gerard Milano, Fabienne Thomas, Marie-Anne Loriot, David J Kerr, Jan H M Schellens, Pierre Laurent-Puig, Qian Shi, Jean-Pierre Pignon, Marie-Christine Etienne-Grimaldi, null null
Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis. British journal of cancer 130 (5) (2024)
Sophie Mouillet-Richard, Antoine Cazelles, Marine Sroussi, Claire Gallois, Gilles Manceau, Pierre Laurent-Puig
Clinical Challenges of Consensus Molecular Subtype CMS4 Colon Cancer in the Era of Precision Medicine. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Gwénaël Le Teuff, Nathalie Cozic, Jean-Christophe Boyer, Valérie Boige, Robert B Diasio, Gilles Manceau, Didier Meulendijks, Claire Palles, Matthias Schwab, Maarten Deenen, Carlo R Largiadèr, Anthony Marinaki, Barbara A Jennings, Yvonne Wettergren, Antonello Di Paolo, Eva Gross, Barna Budai, Stephen P Ackland, André B P van Kuilenburg, Howard L McLeod, Gerard Milano, Fabienne Thomas, Marie-Anne Loriot, David J Kerr, Jan H M Schellens, Pierre Laurent-Puig, Qian Shi, Jean-Pierre Pignon, Marie-Christine Etienne-Grimaldi, null null
Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis. British journal of cancer 130 (5) (2024)
Sophie Mouillet-Richard, Antoine Cazelles, Marine Sroussi, Claire Gallois, Gilles Manceau, Pierre Laurent-Puig
Clinical Challenges of Consensus Molecular Subtype CMS4 Colon Cancer in the Era of Precision Medicine. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Gwénaël Le Teuff, Nathalie Cozic, Jean-Christophe Boyer, Valérie Boige, Robert B Diasio, Gilles Manceau, Didier Meulendijks, Claire Palles, Matthias Schwab, Maarten Deenen, Carlo R Largiadèr, Anthony Marinaki, Barbara A Jennings, Yvonne Wettergren, Antonello Di Paolo, Eva Gross, Barna Budai, Stephen P Ackland, André B P van Kuilenburg, Howard L McLeod, Gerard Milano, Fabienne Thomas, Marie-Anne Loriot, David J Kerr, Jan H M Schellens, Pierre Laurent-Puig, Qian Shi, Jean-Pierre Pignon, Marie-Christine Etienne-Grimaldi, null null
Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis. British journal of cancer 130 (5) (2024)
Claire Gallois, Qian Shi, Levi D Pederson, Thierry André, Timothy J Iveson, Alberto F Sobrero, Steven R Alberts, Aimery deGramont, Jeffrey A Meyerhardt, Thomas J George, Hans-Joachim E Schmoll, Ioannis Souglakos, Andrea Harkin, Roberto Labianca, Frank A Sinicrope, Eiji Oki, Anthony Frank Shields, Ioannis Boukovinas, Rachel Kerr, Sara Lonardi, Greg Yothers, Takayuki Yoshino, Richard M Goldberg, Gilles Manceau, Demetris Papamichael
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
Claire Gallois, Qian Shi, Levi D Pederson, Thierry André, Timothy J Iveson, Alberto F Sobrero, Steven R Alberts, Aimery deGramont, Jeffrey A Meyerhardt, Thomas J George, Hans-Joachim E Schmoll, Ioannis Souglakos, Andrea Harkin, Roberto Labianca, Frank A Sinicrope, Eiji Oki, Anthony Frank Shields, Ioannis Boukovinas, Rachel Kerr, Sara Lonardi, Greg Yothers, Takayuki Yoshino, Richard M Goldberg, Gilles Manceau, Demetris Papamichael
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Thomas Samaille, Antoine Falcoz, Romain Cohen, Pierre Laurent-Puig, Thierry André, Gilles Manceau, Edouard Auclin, Dewi Vernerey
A novel risk classification model integrating CEA, ctDNA, and pTN stage for stage 3 colon cancer: a post hoc analysis of the IDEA-France trial. The oncologist (2024)
Gwénaël Le Teuff, Nathalie Cozic, Jean-Christophe Boyer, Valérie Boige, Robert B Diasio, Gilles Manceau, Didier Meulendijks, Claire Palles, Matthias Schwab, Maarten Deenen, Carlo R Largiadèr, Anthony Marinaki, Barbara A Jennings, Yvonne Wettergren, Antonello Di Paolo, Eva Gross, Barna Budai, Stephen P Ackland, André B P van Kuilenburg, Howard L McLeod, Gerard Milano, Fabienne Thomas, Marie-Anne Loriot, David J Kerr, Jan H M Schellens, Pierre Laurent-Puig, Qian Shi, Jean-Pierre Pignon, Marie-Christine Etienne-Grimaldi, null null
Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis. British journal of cancer 130 (5) (2024)
Gwénaël Le Teuff, Nathalie Cozic, Jean-Christophe Boyer, Valérie Boige, Robert B Diasio, Gilles Manceau, Didier Meulendijks, Claire Palles, Matthias Schwab, Maarten Deenen, Carlo R Largiadèr, Anthony Marinaki, Barbara A Jennings, Yvonne Wettergren, Antonello Di Paolo, Eva Gross, Barna Budai, Stephen P Ackland, André B P van Kuilenburg, Howard L McLeod, Gerard Milano, Fabienne Thomas, Marie-Anne Loriot, David J Kerr, Jan H M Schellens, Pierre Laurent-Puig, Qian Shi, Jean-Pierre Pignon, Marie-Christine Etienne-Grimaldi, null null
Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis. British journal of cancer (2024)
Clémence Flecchia, Edouard Auclin, Emily Alouani, Mathilde Mercier, Antoine Hollebecque, Anthony Turpin, Thibault Mazard, Simon Pernot, Marie Dutherage, Romain Cohen, Christophe Borg, Vincent Hautefeuille, Francesco Sclafani, Meher Ben-Abdelghani, Thomas Aparicio, Christelle De La Fouchardière, Camille Herve, Geraldine Perkins, Kathrin Heinrich, Volker Kunzmann, Claire Gallois, Rosine Guimbaud, David Tougeron, Gilles Manceau
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study. British journal of cancer 130 (3) (2023)
Clémence Flecchia, Edouard Auclin, Emily Alouani, Mathilde Mercier, Antoine Hollebecque, Anthony Turpin, Thibault Mazard, Simon Pernot, Marie Dutherage, Romain Cohen, Christophe Borg, Vincent Hautefeuille, Francesco Sclafani, Meher Ben-Abdelghani, Thomas Aparicio, Christelle De La Fouchardière, Camille Herve, Geraldine Perkins, Kathrin Heinrich, Volker Kunzmann, Claire Gallois, Rosine Guimbaud, David Tougeron, Gilles Manceau
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study. British journal of cancer (2023)
Claire Gallois, Matteo Landi, Gilles Manceau, Marine Sroussi, Bahar Saberzadeh-Ardestani, Antoine Cazelles, Sara Lonardi, Francesca Bergamo, Rossana Intini, Giulia Maddalena, Filippo Pietrantonio, Francesca Corti, Margherita Ambrosini, Antonia Martinetti, Marco Maria Germani, Chiara Boccaccio, Guglielmo Vetere, Sophie Mouillet-Richard, Aurélien de Reyniès, Frank A Sinicrope, Chiara Cremolini, Pierre Laurent-Puig
Transcriptomic Signatures of MSI-high Metastatic Colorectal Cancer Predict Efficacy of Immune Checkpoint Inhibitors. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Clémence Flecchia, Edouard Auclin, Emily Alouani, Mathilde Mercier, Antoine Hollebecque, Anthony Turpin, Thibault Mazard, Simon Pernot, Marie Dutherage, Romain Cohen, Christophe Borg, Vincent Hautefeuille, Francesco Sclafani, Meher Ben-Abdelghani, Thomas Aparicio, Christelle De La Fouchardière, Camille Herve, Geraldine Perkins, Kathrin Heinrich, Volker Kunzmann, Claire Gallois, Rosine Guimbaud, David Tougeron, Gilles Manceau
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study. British journal of cancer 130 (3) (2023)
Gilles Manceau, Timothy Jay Price, Loïck Vidot, Bénédicte Chevallier, Lucjan Wyrwicz, Jean-Baptiste Bachet
Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: final results from the phase IIIb single-arm PRECONNECT study by duration of therapy. BMC cancer 23 (1) (2023)
Sebastian Stinzing, Kathrin Heinrich, David Tougeron, Dominik Paul Modest, Ingo Schwaner, Jan Eucker, Rudolf Pihusch, Martina Stauch, Florian Kaiser, Christoph A Kahl, Meinolf Karthaus, Christian Müller, Christof Burkart, Anke C Reinacher-Schick, Stefan Kasper-Virchow, Ludwig Fischer von Weikersthal, Beate Krammer-Steiner, Gerald Wolfgang Prager, Gilles Manceau, Volker Heinemann
FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of BRAF V600E -Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Eric Van Cutsem, Gilles Manceau, Rona Yaeger, Takayuki Yoshino, Axel Grothey, Evaristo Maiello, Elena Elez, Jeroen Dekervel, Paul J Ross, Ana Ruiz-Casado, Janet Graham, Takeshi Kato, Jose Carlos Ruffinelli, Thierry André, Edith Carrière Roussel, Isabelle Klauck, Mélanie Groc, Jean-Claude Vedovato, Josep Tabernero
ANCHOR CRC: Results From a Single-Arm, Phase II Study of Encorafenib Plus Binimetinib and Cetuximab in Previously Untreated BRAF V600E -Mutant Metastatic Colorectal Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Gilles Manceau, Thomas Seufferlein, Michele Reni, Daniel H Palmer, John A Bridgewater, Antonio Cubillo, Gerald W Prager, Alice Vermeire, Fabienne Hédouin-Biville, Zhaoyang Teng, Teresa Macarulla
Treatment sequences and prognostic/predictive factors in metastatic pancreatic ductal adenocarcinoma: univariate and multivariate analyses of a real-world study in Europe. BMC cancer 23 (1) (2023)
Gilles Manceau, Karoui Medhi
FOxTROT: Are We Ready to Dance? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Clémence Flecchia, Edouard Auclin, Emily Alouani, Mathilde Mercier, Antoine Hollebecque, Anthony Turpin, Thibault Mazard, Simon Pernot, Marie Dutherage, Romain Cohen, Christophe Borg, Vincent Hautefeuille, Francesco Sclafani, Meher Ben-Abdelghani, Thomas Aparicio, Christelle De La Fouchardière, Camille Herve, Geraldine Perkins, Kathrin Heinrich, Volker Kunzmann, Claire Gallois, Rosine Guimbaud, David Tougeron, Gilles Manceau
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study. British journal of cancer 130 (3) (2023)
Clémence Flecchia, Edouard Auclin, Emily Alouani, Mathilde Mercier, Antoine Hollebecque, Anthony Turpin, Thibault Mazard, Simon Pernot, Marie Dutherage, Romain Cohen, Christophe Borg, Vincent Hautefeuille, Francesco Sclafani, Meher Ben-Abdelghani, Thomas Aparicio, Christelle De La Fouchardière, Camille Herve, Geraldine Perkins, Kathrin Heinrich, Volker Kunzmann, Claire Gallois, Rosine Guimbaud, David Tougeron, Gilles Manceau
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study. British journal of cancer 130 (3) (2023)
Gilles Manceau, Timothy Jay Price, Loïck Vidot, Bénédicte Chevallier, Lucjan Wyrwicz, Jean-Baptiste Bachet
Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: final results from the phase IIIb single-arm PRECONNECT study by duration of therapy. BMC cancer 23 (1) (2023)
Gilles Manceau, Karoui Medhi
FOxTROT: Are We Ready to Dance? Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Gilles Manceau, Karoui Medhi
FOxTROT: Are We Ready to Dance? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Clémence Flecchia, Edouard Auclin, Emily Alouani, Mathilde Mercier, Antoine Hollebecque, Anthony Turpin, Thibault Mazard, Simon Pernot, Marie Dutherage, Romain Cohen, Christophe Borg, Vincent Hautefeuille, Francesco Sclafani, Meher Ben-Abdelghani, Thomas Aparicio, Christelle De La Fouchardière, Camille Herve, Geraldine Perkins, Kathrin Heinrich, Volker Kunzmann, Claire Gallois, Rosine Guimbaud, David Tougeron, Gilles Manceau
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study. British journal of cancer 130 (3) (2023)
Gilles Manceau, Timothy Jay Price, Loïck Vidot, Bénédicte Chevallier, Lucjan Wyrwicz, Jean-Baptiste Bachet
Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: final results from the phase IIIb single-arm PRECONNECT study by duration of therapy. BMC cancer 23 (1) (2023)
Gilles Manceau, Timothy Jay Price, Loïck Vidot, Bénédicte Chevallier, Lucjan Wyrwicz, Jean-Baptiste Bachet
Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: final results from the phase IIIb single-arm PRECONNECT study by duration of therapy. BMC cancer 23 (1) (2023)
Claire Gallois, Qian Shi, Jeffrey P Meyers, Timothy J Iveson, Steven R Alberts, Aimery deGramont, Alberto F Sobrero, Daniel G Haller, Eiji Oki, Anthony Frank Shields, Richard M Goldberg, Rachel Kerr, Sara Lonardi, Greg Yothers, Caroline Kelly, Ioannis Boukovinas, Roberto Labianca, Frank A Sinicrope, Ioannis Souglakos, Takayuki Yoshino, Jeffrey A Meyerhardt, Thierry André, Demetris Papamichael, Gilles Manceau
Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Sonia Zaibet, Vincent Hautefeuille, Edouard Auclin, Astrid Lièvre, David Tougeron, Mathieu Sarabi, Marine Gilabert, Julie Wasselin, Julien Edeline, Pascal Artru, Dominique Bechade, Clémence Morin, Agnes Ducoulombier, Gilles Manceau, Simon Pernot
Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study. British journal of cancer 126 (10) (2022)
Catherine Conti, Frederic Pamoukdjian, Thomas Aparicio, Soraya Mebarki, Johanne Poisson, Gilles Manceau, Julien Taieb, Bastien Rance, Sandrine Katsahian, Anaïs Charles-Nelson, Elena Paillaud
Overall Survival and Prognostic Factors among Older Patients with Metastatic Pancreatic Cancer: A Retrospective Analysis Using a Hospital Database. Cancers 14 (5) (2022)
Quang Loc Bui, Léo Mas, Antoine Hollebecque, David Tougeron, Christelle De La Fouchardière, Thomas Pudlarz, Emily Alouani, Rosine Guimbaud, Gilles Manceau, Thierry André, Raphaël Colle, Romain Cohen
Treatments after Immune Checkpoint Inhibitors in Patients with dMMR/MSI Metastatic Colorectal Cancer. Cancers 14 (2) (2022)
Pashtoon Murtaza Kasi, Gordon Fehringer, Hiroya Taniguchi, Naureen Starling, Yoshiaki Nakamura, Daisuke Kotani, Thomas Powles, Bob T Li, Lajos Pusztai, Vasily N Aushev, Ekaterina Kalashnikova, Shruti Sharma, Meenakshi Malhotra, Zachary P Demko, Alexey Aleshin, Angel A Rodriguez, Paul R Billings, Axel Grothey, Gilles Manceau, David Cunningham, Takayuki Yoshino, Scott Kopetz
Impact of Circulating Tumor DNA-Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors. JCO precision oncology 6 (2022)
Thomas Helmberger, Pierleone Lucatelli, Philippe L Pereira, Aleksandar Gjoreski, Ivona Jovanoska, Zoltan Bansaghi, Stavros Spiliopoulos, Francesca Carchesio, Dirk Arnold, Andreas Baierl, Bleranda Zeka, Nathalie C Kaufmann, Gilles Manceau, Roberto Iezzi
Safety, Feasibility and Technical Considerations from a Prospective, Observational Study-CIREL: Irinotecan-TACE for CRLM in 152 Patients. Journal of clinical medicine 11 (20) (2022)
Clémence Canton, Olayidé Boussari, Mathieu Boulin, Karine Le Malicot, Gilles Manceau, Laetitia Dahan, Anthony Lopez, Come Lepage, Jean-Baptiste Bachet
Impact of G-CSF Prophylaxis on Chemotherapy Dose-Intensity, Link Between Dose-Intensity and Survival in Patients with Metastatic Pancreatic Adenocarcinoma. The oncologist 27 (7) (2022)
Zhaohui Jin, Jesse G Dixon, Jack M Fiskum, Hiral D Parekh, Frank A Sinicrope, Greg Yothers, Carmen J Allegra, Norman Wolmark, Daniel G Haller, Hans-Joachim Schmoll, Aimery de Gramont, Rachel S Kerr, Gilles Manceau, Eric Van Cutsem, Christopher Tweleves, Michael O'Connell, Leonard B Saltz, Sotaro Sadahiro, Charles David Blanke, Naohiro Tomita, Jean-Francois Seitz, Charles Erlichman, Takayuki Yoshino, Takeharu Yamanaka, Silvia Marsoni, Thierry André, Amit Mahipal, Richard M Goldberg, Thomas J George, Qian Shi
Clinicopathological and Molecular Characteristics of Early-Onset Stage III Colon Adenocarcinoma: An Analysis of the ACCENT Database. Journal of the National Cancer Institute (2021)
Emilie Moati, Valerie Taly, Simon Garinet, Audrey Didelot, Gilles Manceau, Pierre Laurent-Puig, Aziz Zaanan
Role of Circulating Tumor DNA in Gastrointestinal Cancers: Current Knowledge and Perspectives. Cancers 13 (19) (2021)
Tae Won Kim, Gilles Manceau, Ellen B Gurary, Nati Lerman, Karen Y Cui, Takayuki Yoshino
Olaparib with or without bevacizumab or bevacizumab and 5-fluorouracil in advanced colorectal cancer: Phase III LYNK-003. Future oncology (London, England) 17 (36) (2021)
Elisa Fontana, Jeff Meyers, Alberto F Sobrero, Timothy J Iveson, Anthony F Shields, Gilles Manceau, Takayuki Yoshino, Ioannis Souglakos, Elizabeth C Smyth, Florian Lordick, Markus Möhler, Anne Giraut, Andrea Harkin, Roberto Labianca, Jeffrey Meyerhardt, Thierry André, Ioannis Boukovinas, Sara Lonardi, Mark Saunders, Dewi Vernerey, Eiji Oki, Vassilis Georgoulias, Irit Ben-Aharon, Qian Shi
Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Laetitia Marisa, Yuna Blum, Gilles Manceau, Mira Ayadi, Camilla Pilati, Karine Le Malicot, Côme Lepage, Ramón Salazar, Daniela Aust, Alex Duval, Hélène Blons, Valérie Taly, David Gentien, Audrey Rapinat, Janick Selves, Sophie Mouillet-Richard, Valérie Boige, Jean François Emile, Aurélien de Reyniès, Pierre Laurent-Puig
Intratumor CMS Heterogeneity Impacts Patient Prognosis in Localized Colon Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (17) (2021)
Edouard Auclin, Perrine Vuagnat, Cristina Smolenschi, Gilles Manceau, Jorge Adeva, Laetitia Nebot-Bral, Marta Garcia de Herreros, Rosario Vidal Tocino, Federico Longo-Muñoz, Yola El Dakdouki, Patricia Martín-Romano, Lydia Gaba, Tamara Saurí, Helena Oliveres, Eduardo Castañón, Rocio Garcia-Carbonero, Benjamin Besse, Christophe Massard, Laura Mezquita, Antoine Hollebecque
Association of the Lung Immune Prognostic Index with Immunotherapy Outcomes in Mismatch Repair Deficient Tumors. Cancers 13 (15) (2021)
Arnaud Bayle, Debora Basile, Simon Garinet, Bastien Rance, Pierre Laurent-Puig, Hélène Blons, Gilles Manceau, Geraldine Perkins
Next-Generation Sequencing Targeted Panel in Routine Care for Metastatic Colon Cancers. Cancers 13 (22) (2021)
Edouard Auclin, Lysiane Marthey, Raef Abdallah, Léo Mas, Eric Francois, Angélique Saint, Antonio Sa Cunha, Angélique Vienot, Thierry Lecomte, Vincent Hautefeuille, Christelle De La Fouchardière, Matthieu Sarabi, Feryel Ksontini, Julien Forestier, Romain Coriat, Emmanuelle Fabiano, Florence Leroy, Nicolas Williet, Jean-Baptiste Bachet, David Tougeron, Gilles Manceau
Role of FOLFIRINOX and chemoradiotherapy in locally advanced and borderline resectable pancreatic adenocarcinoma: update of the AGEO cohort. British journal of cancer 124 (12) (2021)
Gilles Manceau, Valérie Taly, Julie Henriques, Camille Bourreau, Laurent Mineur, Jaafar Bennouna, Jérôme Desrame, Christophe Louvet, Céline Lepere, May Mabro, Joëlle Egreteau, Olivier Bouche, Claire Mulot, Katia Hormigos, Kariman Chaba, Thibault Mazard, Aimery deGramont, Dewi Vernerey, Thierry André, Pierre Laurent-Puig
Prognostic Value and Relation with Adjuvant Treatment Duration of ctDNA in Stage III Colon Cancer: a Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (20) (2021)
Nicolas Williet, Angelica Petrillo, Gaël S Roth, Michele Ghidini, Mila Petrova, Julien Forestier, Anthony Lopez, Audrey Thoor, Lucie Weislinger, Ferdinando De Vita, Gilles Manceau, Jean Marc Phelip
Gemcitabine/Nab-Paclitaxel versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: A European Multicenter Study. Cancers 13 (11) (2021)
Juliette Palle, Laure Hirsch, Alexandra Lapeyre-Prost, David Malka, Morgane Bourhis, Simon Pernot, Elie Marcheteau, Thibault Voron, Florence Castan, Ariane Lacotte, Nadine Benhamouda, Corinne Tanchot, Eric François, François Ghiringhelli, Christelle De La Fouchardière, Aziz Zaanan, Eric Tartour, Gilles Manceau, Magali Terme
Targeting HGF/c-Met Axis Decreases Circulating Regulatory T Cells Accumulation in Gastric Cancer Patients. Cancers 13 (21) (2021)
George Kafatos, Victoria L Banks, Peter Burdon, David Neasham, Caroline Anger, Fil Manuguid, Kimberly A Lowe, Patrick Cheung, Gilles Manceau, Joannes Han van Krieken
Biomarker testing and mutation prevalence in metastatic colorectal cancer patients in five European countries using a large oncology database. Future oncology (London, England) 17 (12) (2021)
Gilles Manceau, Gerald W Prager, Davide Melisi, C Benedikt Westphalen, Nathalie D'Esquermes, Anabel Ferreras, Alfredo Carrato, Teresa Macarulla
First-line and second-line treatment of patients with metastatic pancreatic adenocarcinoma in routine clinical practice across Europe: a retrospective, observational chart review study. ESMO open 5 (1) (2021)
Daniel Pietrasz, Shufang Wang-Renault, Gilles Manceau, Laetitia Dahan, Mathilde Postel, Jerome Durand-Labrunie, Karine Le Malicot, Claire Mulot, Yves Rinaldi, Jean-Marc Phelip, Solene Doat, Hélène Blons, Aurelien de Reynies, Jean-Baptiste Bachet, Valérie Taly, Pierre Laurent-Puig
Prognostic value of circulating tumour DNA in metastatic pancreatic cancer patients: post-hoc analyses of two clinical trials. British journal of cancer (2021)
Romain Cohen, Gilles Manceau, Jack Fiskum, Greg Yothers, Richard M Goldberg, Takayuki Yoshino, Steven R Alberts, Carmen Allegra, Aimery de Gramont, Jean-Francois Seitz, Michael O'Connell, Daniel Haller, Norman Wolmark, Charles Erlichman, Alberto Zaniboni, Sara Lonardi, Rachel Kerr, Axel Grothey, Frank A Sinicrope, Thierry André, Qian Shi
Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (6) (2020)
Markus Möhler, Mikhail Dvorkin, Narikazu Boku, Mustafa Özgüroğlu, Min-Hee Ryu, Alina S Muntean, Sara Lonardi, Marina Nechaeva, Arinilda C Bragagnoli, Hasan S Coşkun, Antonio Cubillo Gracian, Toshimi Takano, Rachel Wong, Howard Safran, Gina M Vaccaro, Zev A Wainberg, Matthew R Silver, Huiling Xiong, Janet Hong, Gilles Manceau, Yung-Jue Bang
Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (9) (2020)
Gilles Manceau, Andreas Jung, Andrea Sartore-Bianchi, Marc Peeters, Jenny Seligmann, Aziz Zaanan, Peter Burdon, Clara Montagut, Pierre Laurent-Puig
The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer. Drugs 79 (13) (2020)
Leo Mas, Jean-Baptiste Bachet, Valerie Taly, Olivier Bouché, Gilles Manceau, Romain Cohen, Aurelia Meurisse, Corinne Normand, Jean-Marc Gornet, Pascal Artru, Samy Louafi, Anne Thirot-Bidault, Isabelle Baumgaertner, Romain Coriat, David Tougeron, Thierry Lecomte, Florence Mary, Thomas Aparicio, Lysiane Marthey, Helene Blons, Dewi Vernerey, Pierre Laurent-Puig
BRAF Mutation Status in Circulating Tumor DNA from Patients with Metastatic Colorectal Cancer: Extended Mutation Analysis from the AGEO RASANC Study. Cancers 11 (7) (2019)
Gilles Manceau, Fernando Rivera, Salvatore Siena, Meinolf Karthaus, Manuel Valladares-Ayerbes, Javier Gallego, Michael Geissler, Reija Koukakis, Gaston Demonty, Marc Peeters
Exploratory analyses assessing the impact of early tumour shrinkage and depth of response on survival outcomes in patients with RAS wild-type metastatic colorectal cancer receiving treatment in three randomised panitumumab trials. Journal of cancer research and clinical oncology 144 (2) (2017)

Gilles Manceau.css-eqlu8i{font-size:small;padding-left:4px;} (Julien Taieb)

Publication Activity (10 Years)

Top Topics

Top Venues

Gilles Manceau (Julien Taieb)